Investing in your 20s? These emerging growth candidates could help you retire earlier

Younger investors are better placed to face the risks of growth investing. Here are two that might earn you some serious cash.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As I’m getting older I’m becoming far more wary of the risks of ‘jam tomorrow’ growth investments, but if you have the horizon for them, it can be a profitable strategy. Here are two that a younger me would have found very exciting.

The fatness epidemic

The first is OptiBiotix Health (LSE: OPTI), which develops products aimed at tackling the problems of obesity, high cholesterol and diabetes — all very big issues in the overfed developed world. The company’s bottom line is starting to turn upwards, and there have been some key developments that convince me that serious profit might not be too far away now.

On Thursday the company announced “an evaluation agreement with a global dairy company for its SweetBiotix calorie-free sweet fibres,” which could see them ending up in a range of products. We don’t know which company it is, but according to CEO Stephen O’Hara, it’s a well-known global brand.

This news comes a week after the firm’s annual results were released, for a year it says is part of a “transition from a development company into a commercial business.

OptiBiotix reported a profit-sharing agreement with Sacco among 10 commercial deals agreed in the period. Its SlimBiome product won a Food Matters award for Best Functional Ingredient for Health and Wellbeing, and FDA registration for LP-LDL and SlimBiome are paving the way for sales in the US.

There was even a small pre-tax profit, of £1.69m. And OptiBiotix looks to be in a comfortable financial position, having just raised £1.5m through a new equity offering.

My colleague G A Chester recently rated it a high-risk buy, and I agree with him.

Cash cow already

When I examined XLMedia (LSE: XLM) early last year, the shares had nearly three-bagged since 2014 and I saw the stock as a very tempting proposition. Since then the share price has put on a further 50%, as the company is firmly in that territory envied by many a growth startup — it’s in the transformation from growth prospect to dividend-paying cash cow.

The company, which bills itself as a provider of “digital performance marketing services,” saw its 2017 revenues grow by 33%, with adjusted EBITDA up 36% and earnings per share up 25%. And it had plenty of cash on the books and no debt.

The shares have actually fallen back a little since the end of 2017 as earnings forecasts have been pared back a little. But that’s a common phenomenon with growth stocks, and I reckon it still leaves the shares on a pretty attractive valuation.

We’re not looking at the super-low PEG ratios of recent years as EPS has been making annual double-digit percentage leaps, and the latter is expected to be flat this year. But a return to growth with 8% indicated for 2019 would put XLMedia on a P/E of a little under 15 — and that’s with dividends set to already yield 3.5% by then.

For a company in a growing market, with significant further growth potential, and already bring in pots of cash and paying decent dividends, I reckon that’s a bargain price. And $43.3m (£34.5m) in cash at year-end for a debt-free company with a market cap of £360m isn’t too shabby either.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much would I need to invest in income shares to earn £300 a month?

What kind of lump sum would be required to earn £300 a month by taking advantage of some of the…

Read more »

Investing For Beginners

Up 31% in a month, could this FTSE 250 stock be getting bought out?

Jon Smith takes a look at speculation that's pushing the share price of a FTSE 250 share higher and considers…

Read more »

Investing Articles

Here’s how I’d follow Warren Buffett to start building passive income in 2025

Ben McPoland highlights one FTSE 250 firm with a strong competitive edge that he thinks can continue rewarding investors with…

Read more »

Investing Articles

Burberry shares: undervalued FTSE gems that are ready to rocket?

Burberry shares soared at the beginning of the week as the takeover rumour mill went into overdrive. Is Paul Summers…

Read more »

US Stock

Here are the latest share price forecasts for S&P 500 giant Amazon

Amazon has generated monster gains for investors over the last decade. And Wall Street analysts believe the S&P 500 stock…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

2 high-yield FTSE 250 shares I’d buy today — and 1 that I’d avoid

UK markets have felt some volatility after last week’s Budget and the FTSE 250 was no stranger to it. Our…

Read more »

Investing Articles

3 reasons the Rolls-Royce share price could soar over the next decade

Sustainable aviation fuel, narrow-body aircraft, and small nuclear reactors could all keep the Rolls-Royce share price climbing over the next…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in cheap BT shares

BT shares are on the up but still cheap, while the FTSE 100 telecoms stock offers a good yield too.…

Read more »